6386 J . Org. Chem., Vol. 63, No. 18, 1998
Kataoka et al.
128.2, 128.1, 128.0, 127.5, 126.9, 120.5, 31.8; MS m/z (relative
intensity) 262 (100, M+), 261 (95), 185 (14); HRMS calcd for
C18H14O2 (M+) 262.0994, found 262.1001.
Decom p osition of 8a . (a) A solution of compound 8a (96
mg, 0.20 mmol) in chloroform (3 mL) was stirred at room
temperature for 3 d. After the solution was concentrated, the
residue was purified by preparative TLC (5:1 hexanes-ethyl
acetate) to give 7a (38 mg, 81%) and 6f (38 mg, 77%). (b) A
solution of compound 8a (128 mg, 0.27 mmol) in chloroform
(10 mL) was refluxed for 8 h and similarly worked up as above
to give 7a (53 mg, 85%) and 6f (57 mg, 87%).
Tr ea tm en t of 8a w ith Iod om eth a n e. Compound 8a (96
mg, 0.20 mmol) was stirred with 95% iodomethane (300 mg,
2.0 mmol) in chloroform (3 mL) at room temperature for 3 d.
After the solution was concentrated, the residue was purified
by preparative TLC (5:1 hexanes-ethyl acetate) to give 7a (42
mg, 90%) and 6f (37 mg, 75%).
3-Ben zoyl-2,4-d ip h en ylfu r a n (6c): colorless oil; IR (neat)
1
1660 cm-1; H NMR (CDCl3) δ 7.85 (d, 2H), 7.67 (s, 1H), 7.58
(d, 2H), 7.42 (t, 1H), 7.28-7.17 (m, 10H); 13C NMR (CDCl3) δ
193.8, 153.4, 138.6, 137.4, 133.5, 131.1, 129.8, 129.7, 128.9,
128.5, 128.4, 127.8, 127.4, 126.4, 120.3; MS m/z (relative
intensity) 324 (100, M+), 247 (25), 105 (67); HRMS calcd for
C
23H16O2 (M+) 324.1150, found 324.1160.
Meth yl 2-m eth yl-4-p h en yl-3-fu r a n ca r boxyla te (6d ): col-
1
orless oil; IR (neat) 1716 cm-1; H NMR (CDCl3) δ 7.36-7.30
(m, 5H), 7.26 (s, 1H), 3.71 (s, 3H), 2.60 (s, 3H); 13C NMR
(CDCl3) δ 164.5, 160.3, 138.3, 131.9, 129.1, 127.8, 127.4, 127.3,
112.5, 51.0, 14.3; MS m/z (relative intensity) 216 (100, M+),
185 (64), 184 (60), 128 (47), 127 (33). Anal. Calcd for
Decom p osition of 8b. A solution of compound 8b (62 mg,
0.13 mmol) in chloroform (10 mL) was treated in a manner
similar to that for 8a and gave 7a (18 mg, 60%), 6g (4 mg,
13%), and 9a (18 mg, 29%).
C
13H12O3: C, 72.21; H, 5.59. Found: C, 72.28; H, 5.78.
Eth yl 2,4-d ip h en yl-3-fu r a n ca r boxyla te (6e): colorless
Decom p osition of 8c. A solution of compound 8c (92 mg,
0.18 mmol) in chloroform (10 mL) was treated in a manner
similar to that for 8a and gave 7b (41 mg, 87%), 6g (23 mg,
52%), and a mixture of (E)- and (Z)-3-p-methylphenoxy-2-[1-
phenyl-2-(p-tolylseleno)ethenyl]inden-1-one 9b (4 mg, 4%).
oil; IR (neat) 1720 cm-1; 1H NMR (CDCl3) δ 7.82 (d, 2H), 7.49
(s, 1H), 7.46-7.32 (m, 8H), 4.18 (q, 2H), 1.07 (t, 3H); 13C NMR
(CDCl3) δ 164.6, 156.5, 139.0, 131.7, 129.9, 129.1, 128.7, 128.5,
128.2, 128.1, 127.7, 127.5, 113.9, 60.8, 13.7; MS m/z (relative
intensity) 292 (100, M+), 247 (53), 105 (83); HRMS calcd for
1
9b: pale yellow oil; IR (neat) 1707 cm-1; H NMR (CDCl3) δ
C
19H16O3 (M+) 292.1099, found 292.1107.
7.99 (m, 0.5H), 7.90 (m, 2H), 7.81 (m, 0.5H), 7.74 (m, 2H), 7.
49 (d, 2H), 7.28-7.01 (m, 17H), 6.95 (d, 0.5H), 6.88 (s, 0.25H),
6.57 (s, 1H), 2.29 (s, 6H), 2.27 (s, 0.75H), 2.19 (s, 0.75H); MS
m/z (relative intensity) 508 (35, M+), 506 (18), 337 (100), 309
(20), 265 (45); HRMS calcd for C31H24O2Se (M+) 508.0941,
found 508.0936.
5-Cya n o-2,2,4,6-tetr a p h en yl-1,2-oxa selen in (8a ) was ob-
tained as a pale yellow powder. This compound was pure
enough to use its analysis and reactions: mp 139-141 °C dec;
1
IR (KBr) 2185 cm-1; H NMR (CDCl3) δ 7.64 (d, 4H), 7.58-
7.49 (m, 7H), 7.43-7.36 (m, 5H), 7.28-7.24 (m, 4H), 5.45 (s,
1H); 13C NMR (CDCl3) δ 186.0, 157.0, 141.01, 140.97, 132.7,
131.8, 130.5, 129.7, 129.5, 129.30, 129.27, 129.0, 128.4, 127.6,
127.5, 124.7, 95.6, 79.7; 77Se NMR (CDCl3) δ 462.2; 77Se CP-
MAS NMR δ 454.1; FAB MS m/z 480 (M + 1)+. Anal. Calcd
for C29H21NOSe: C, 72.80; H, 4.42; N, 2.93. Found: C, 72.67;
H, 4.42; N, 2.84.
Cr ossover Rea ction of 8b a n d 8c. A solution of the
mixture of 8b (73 mg, 0.15 mmol) and 8c (77 mg, 0.15 mmol)
in chloroform (10 mL) was refluxed for 3 d. After the solution
was concentrated, the residue was purified by preparative TLC
(5:1 hexanes-ethyl acetate) to give a mixture of 7a (31 mg,
87%) and 7b (34 mg, 86%), 6g (27 mg, 36%), a mixture of 9a
(7 mg, 8%) and 9b (1 mg, 2%), and an unidentified product
(27 mg). The ratio of the products in a mixture was deter-
3-Cya n o-2,4-d ip h en ylfu r a n (6f): white powder; mp 89 °C;
1
IR (neat) 2231 cm-1; H NMR (CDCl3) δ 8.03 (d, 2H), 7.63 (d,
2H), 7.62 (s, 1H), 7.51-7.43 (m, 5H), 7.38 (t, 1H); 13C NMR
(CDCl3) δ 161.0, 138.3, 130.2, 129.2, 129.0, 128.7, 128.5, 128.0,
126.9, 125.5, 115.2, 91.5; MS m/z (relative intensity) 245 (100,
M+), 216 (35), 189 (15); HRMS calcd for C17H11NO (M+)
245.0841, found 245.0848.
1
mined by H NMR.
Gen er a l P r oced u r e for Rea ction s of Alk yn ylselen on -
iu m Sa lts 1a w ith Am id es 13. A Typ ica l Exa m p le (Ta ble
4, En tr y 1). To a stirred solution of benzamide 13a (24 mg,
0.20 mmol) in THF (3 mL) was added 60% NaH (8 mg, 0.20
mmol) at room temperature under argon. After the mixture
was stirred for 30 min, the selenonium triflate 1a (97 mg, 0.20
mmol) was added, and then the mixture was refluxed for 3 h.
The mixture was quenched with NH4Cl (aq) and extracted with
chloroform. The organic phase was washed with brine, dried
over anhydrous MgSO4, and concentrated. Preparative TLC
(5:1 hexanes-ethyl acetate and 10:1 chloroform-methanol) of
the crude product gave 2,4-diphenyloxazole 14a (22 mg, 50%),
7a (26 mg, 56%), and 2a (20 mg, 40%). 14a : a white powder;
2,2,4-Tr ip h en yl-5H-in d en o[1,2-e]-1,2-oxa selen in (8b):
1
yellow powder; mp 146-148 °C dec; IR (KBr) 1660 cm-1; H
NMR (CDCl3) δ 7.67 (d, 4H), 7.60-7.51 (m, 6H), 7.50-7.46
(m, 2H), 7.43-7.31 (m, 7H), 5.55 (s, 1H); 13C NMR (CDCl3) δ
190.4, 156.3, 139.9, 139.4, 133.3, 131.8, 130.9, 130.5, 130.0,
129.3, 129.2, 128.8, 127.9, 119.4, 104.4, 96.2; 77Se NMR (CDCl3)
δ 476.2; 77Se CP-MAS NMR δ 451.3; MS m/z 480 (M+). Anal.
Calcd for C29H20O2Se‚1/2H2O: C, 71.31; H, 4.33. Found: C,
71.06; H, 4.54.
1
mp 101-102 °C; H NMR (CDCl3) δ 8.15-8.11 (m, 2H), 7.97
4-P h en yl-2,2-d i-p -t olyl-5H -in d en o[1,2-e]-1,2-oxa sele-
n in (8c): yellow powder: mp 119-123 °C dec; IR (neat) 1680
cm-1; 1H NMR (CDCl3) δ 7.53 (d, 4H), 7.49-7.46 (m, 2H), 7.41
(d, 2H), 7.39-7.36 (m, 2H), 7.35-7.31 (m, 7H) 5.54 (s, 1H),
2.42 (s, 6H); 13C NMR (CDCl3) δ 190.4, 155.7, 142.5, 140.0,
139.9, 139.4, 131.2, 130.9, 122.9, 129.8, 129.2, 128.7, 127.9,
119.3, 104.3, 97.3, 21.3; MS m/z 508 (M+). Anal. Calcd for
C13H12O3: C, 72.21; H, 5.59. Found: C, 72.28; H, 5.78.
3-P h en yl-4H-in d en o[1,2-b]fu r a n -4-on e (6g): yellow pow-
der; mp 129-130 °C; IR (neat) 1706 cm-1; 1H NMR (CDCl3) δ
7.88 (d, 2H), 7.78 (s, 1H), 7.51 (d, 1H), 7.43 (t, 2H), 7.33 (t,
2H), 7.22 (t, 1H), 7.16 (d, 1H); 13C NMR (CDCl3) δ 184.9, 176.0,
143.6, 138.4, 133.7, 133.0, 129.9, 129.2, 128.9, 128.2, 126.8,
126.0, 123.9, 121.6, 117.2; MS m/z (relative intensity) 246 (100,
M+), 189 (50); HRMS calcd for C17H10O2 (M+) 246.0681, found
246.0686.
(s, 1H), 7.83 (d, 2H), 7.51-7.46 (m, 3H), 7.43 (t, 2H), 7.34 (t,
1H); 13C NMR (CDCl3) δ 161.9, 142.0, 133.4, 133.4, 131.1,
130.4, 128.7, 128.1, 127.5, 126.5, 125.6; MS m/z (relative
intensity) 221 (100, M+), 193 (83). The melting point and
spectral data were identical with those of an authentic sample
in the literature.15
2-ter t-Bu tyl-4-p h en yloxa zole (14b):16 colorless oil; IR
(neat) 1566 cm-1; 1H NMR (CDCl3) δ 7.79 (s, 1H), 7.73 (d, 2H),
7.38 (t, 2H), 7.28 (t, 1H), 1.43 (s, 9H); 13C NMR (CDCl3) δ 171.5,
140.2, 132.7, 131.5, 128.6, 127.7, 125.6, 33.8, 28.6; MS m/z
(relative intensity) 201 (100, M+), 186 (73); HRMS calcd for
C13H15NO (M+) 201.1154, found 201.1150.
Ackn owledgm en t. The authors thank Central Glass
Co., Ltd, (Tokyo, J apan) for a generous gift of trifluo-
romethanesulfonic anhydride.
3-P h en oxy-2-[1-ph en yl-2-(ph en ylselen o)eth en yl]in den -
1-on e (9a ): pale yellow oil: IR (neat) 1707 cm-1 1H NMR
;
Su p p or tin g In for m a tion Ava ila ble: Details of the crys-
tallographic analysis of 8a (10 pages). This material is
contained in libraries on microfiche, immediately follows this
article in the microfilm version of the journal, and can be
ordered from the ACS; see any current masthead page for
ordering information.
(CDCl3) δ 8.01 (m, 2H), 7.82 (m, 2H), 7.37-7.31 (m, 4H), 7.21-
7.07 (m, 11H), 6.93 (s, 1H); 13C NMR (CDCl3) δ 198.4, 143.2,
142.4, 135.7, 135.5, 132.2, 131.8, 129.4, 129.2, 128.5, 128.4,
127.9, 127.7, 127.6, 127.5, 127.3, 126.7, 123.9, 70.5; 77Se NMR
(CDCl3) δ 395.4; MS m/z (relative intensity) 480 (37, M+), 323
(100), 247 (40); HRMS calcd for C29H20O2Se (M+) 480.0628,
found 480.0622.
J O980999X